miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod
Abstract Background Multiple sclerosis (MS) is a disabling autoimmune demyelinating disorder affecting young people and causing significant disability. In the last decade, different microRNA (miRNA) expression patterns have been associated to several treatment response therapies such as interferon a...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2023-05-01
|
| Colección: | Journal of Neuroinflammation |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s12974-023-02811-z |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|